GITR Antibodies

Santa Cruz Biotechnology features a diverse variety of GITR Antibodies for immunology and cell signaling research. GITR Antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). GITR, or Glucocorticoid-Induced TNFR-Related Protein, plays a crucial role in regulating immune responses and maintaining immune homeostasis. GITR is primarily expressed on activated T cells and is involved in modulating T cell activation and proliferation, making it an important target for studies related to autoimmune diseases and cancer immunotherapy. Understanding GITR function is essential for developing therapeutic strategies aimed at enhancing or inhibiting immune responses. Researchers can explore GITR expression patterns across different cell types and tissues to better understand its biological significance. Advanced imaging techniques combined with GITR monoclonal antibodies enable detailed visualization of protein localization and interactions. Investigating GITR signaling pathways provides insights into immune system regulation and potential therapeutic targets. Santa Cruz Biotechnology monoclonal antibodies for GITR research support scientists worldwide in advancing our understanding of immune system regulation and developing new therapeutic approaches.